María José Guzmán Pavón

Dr. María José Guzmán Pavón

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2023 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Open access
EGEva Rodríguez Gutiérrez
Eva Rodríguez Gutiérrez
ATAna Torres-Costoso
Ana Torres-Costoso
ASAlicia Saz-Lara
Alicia Saz-Lara
BPBruno Bizzozero Peroni
Bruno Bizzozero Peroni
MPMaría José Guzmán Pavón
María José Guzmán Pavón
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
Background: High‐intensity interval training (HIIT) has emerged as an alternative training method to increase brain‐derived neurotrophic factor (BDNF) levels, a crucial molecule involved in plastic brain changes. Its effect compared to moderate‐intensity continuous training (MICT) is controversial. We aimed to estimate, and to comparatively evaluate, the acute and chronic effects on peripheral BDNF levels after a HIIT, MICT intervention or a control condition in adults.Methods: The CINAHL, Cochrane, PubMed, PEDro, Scopus, SPORTDiscus, and Web of Science databases were searched for randomized controlled trials (RCTs) from inception to June 30, 2023. A network meta‐analysis was performed to assess the acute and chronic effects of HIIT versus control condition, HIIT versus MICT and MICT versus control condition on BDNF levels. Pooled standardized mean differences (SMDs) and their 95% confidence intervals (95% CIs) were calculated for RCTs using a random‐effects model.Results: A total of 22 RCTs were selected for the systematic review, with 656 participants (aged 20.4–79 years, 34.0% females) and 20 were selected for the network meta‐analysis. Network SMD estimates were significant for HIIT versus control condition (1.49, 95% CI: 0.61, 2.38) and MICT versus control condition (1.08, 95% CI: 0.04, 2.12) for acutely BDNF increase. However, pairwise comparisons only resulted in a significant effect for HIIT versus control condition.Conclusions: HIIT is the best training modality for acutely increasing peripheral BDNF levels in adults. HIIT may effectively increase BDNF levels in the long term.

1 May 2022 in Annals of Physical and Rehabilitation Medicine
Verified
Journal Article
Open access
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
PMPurificación López Muñoz
Purificación López Muñoz
ATAna Torres-Costoso
Ana Torres-Costoso
There is overwhelming evidence regarding the beneficial effects of exercise on the management of symptoms, functionality and health-related quality of life (HRQoL) of people with multiple sclerosis (MS). However, few analyze have compared different types of exercise. The aim of this network meta-analysis (NMA) was to assess which type of physical exercise has the greatest positive effect on HRQoL in people with MS. MEDLINE, Cochrane Library, Embase, Web of Science, Physiotherapy Evidence Database and SPORTDiscus databases were searched from inception to June 2021 to identify randomized controlled trials (RCTs) examining the effect of physical exercise on HRQoL in people with MS. The NMA included pairwise and indirect comparisons. We ranked the effect of interventions calculating the surface under the cumulative ranking (SUCRA). We included 45 RCTs in this NMA (2428 participants; 76% women; mean age 45 years). Five types of physical exercises were ranked. Sensorimotor training had the highest effect size (0.87, 95% confidence interval [CI] 0.60; 1.15) and the highest SUCRA (87%) for total HRQoL. The highest effect size and SUCRA for physical and mental HRQoL were for aerobic exercise (0.85, 95% CI 0.28; 1.42) (89%) and mind-body exercises (0.54, 95% CI 0.03; 1.06) (89%). Sensorimotor training was the best exercise for mild disease and aerobic exercise for severe disease for total HRQoL. Sensorimotor training seems the most effective exercise to improve HRQoL and aerobic and mind-body exercises to improve physical and mental HRQoL, respectively.

SPSusana Priego-Jiménez
Susana Priego-Jiménez
ATAna Torres-Costoso
Ana Torres-Costoso
MPMaría José Guzmán Pavón
María José Guzmán Pavón
PLPatricia Lorenzo-García
Patricia Lorenzo-García
MLMaría Isabel Lucerón-Lucas-Torres
María Isabel Lucerón-Lucas-Torres
CÁCelia Álvarez-Bueno
Celia Álvarez-Bueno
Aim: A network meta-analysis (NMA) was performed to determine the effects on the exercise capacity, measured by the 6 MWT, of patients with COPD of (i) different physical activity interventions and (ii) supervised or unsupervised programs. Methods: A literature search was carried out from inception to April 2022. Randomized controlled trials of the effectiveness of physical activity on exercise capacity in patients with COPD were included. The risk of bias was assessed using the Cochrane Risk of Bias (RoB 2.0) tool, and the Grading of Recommendations, Assessment, Development, and Evaluation tool (GRADE) was used to assess the quality of the evidence. A pairwise meta-analysis for direct and indirect effects was carried out. Results: A total of 41 studies were included in this NMA. The highest effects were for urban training pulmonary rehabilitation (PR) programs (ES, 1.50; 95% CI: 0.46 and 2.55) versus the control group. For supervised and unsupervised PR and home-based PR programs, the highest effects were found for supervised PR (ES, 0.85; 95% CI: 0.46 to 1.23) versus the control group. Conclusions: PR implemented with urban circuit training should be considered the most effective strategy to improve exercise capacity in patients with COPD. Supervision of the programs improves exercise capacity.

24 June 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
PMPurificación López Muñoz
Purificación López Muñoz
ATAna Torres-Costoso
Ana Torres-Costoso
Rubén Fernández-RodríguezRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
MPMaría José Guzmán Pavón
María José Guzmán Pavón
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
Vitamin D supplementation has been considered a possible treatment to reduce the risk of disease activity and progression in people with multiple sclerosis (MS). However, its effect on disease symptoms remains unclear. The aim of this meta-analysis was to conduct a systematic review to assess the effect of vitamin D on fatigue in this population. The systematic review was conducted using the MEDLINE, Cochrane Library, Embase and Web of Science databases from inception to May 2023. Randomized controlled trials (RCTs) reporting pre–post changes in fatigue after vitamin D supplementation were included. Pooled effect sizes and 95% confidence intervals (95% CIs) were calculated by applying a random effects model with Stata/SE (Version 16.0; StataCorp., College Station, TX, USA). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines were followed. A total of five studies with 345 individuals (271 females; age range: 25.4–41.1 years) were included. A significant reduction in fatigue was perceived when vitamin D supplementation was compared with a control group: −0.18 (95% CI: −0.36 to −0.01; I2 = 0%). Thus, our findings show that the therapeutic use of vitamin D on fatigue in people with MS could be considered. Nevertheless, due to the lack of agreement on the dose to be applied, it is recommended to use it under medical prescription.

1 August 2022 in Journal of Orthopaedic & Sports Physical Therapy
Verified
Journal Article
Closed access
SASergio Nuñez de Arenas-Arroyo
Sergio Nuñez de Arenas-Arroyo
Iván Cavero RedondoIván Cavero Redondo
Iván Cavero Redondo
ATAna Torres-Costoso
Ana Torres-Costoso
SRSara Reina-Gutiérrez
Sara Reina-Gutiérrez
MPMaría José Guzmán Pavón
María José Guzmán Pavón
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino
Objective: To estimate the screening performances of the most important provocation tests for diagnosing carpal tunnel syndrome (CTS). Design: Diagnostic test accuracy systematic review with meta-analysis. Literature Search: We systematically searched the MEDLINE, Scopus, Web of Science, and Cochrane databases from inception to November 2020. Study Selection Criteria: Observational studies comparing the accuracies of the Durkan test (DT), the hand elevation test (HET), the Phalen test (PT), the Tinel test (TT), and the upper-limb neurodynamic test specific to the median nerve (ULNT1) with electrodiagnosis for screening for CTS. Data Synthesis: Random-effects models for the diagnostic odds ratio (dOR) values computed by Moses' constant for a linear model and 95% confidence intervals (CIs) were used to calculate the accuracy of these tests. Hierarchical summary receiver operating characteristic curve analyses were used to summarize the overall test performance. Results: Thirty-seven studies were included in the meta-analysis, with a total sample of 2662 wrists for DT, 864 wrists for HET, 6361 wrists for PT, 6094 wrists for TT, and 571 wrists for ULNT1. The pooled dORs for screening for CTS were 15.84 (95% CI: 3.78, 66.38) for DT, 128.63 (95% CI: 40.64, 407.12) for HET, 7.23 (95% CI: 4.06, 12.86) for PT, 5.31 (95% CI: 3.49, 8.09) for TT, and 1.78 (95% CI: 0.61, 5.19) for ULNT1. Conclusion: HET has the best clinical performance for detecting CTS and should be considered the first screening test of choice during the physical examination. The most common tests (DT, PT, and TT) have good accuracies for screening for CTS. J Orthop Sports Phys Ther 2022;52(8):522–531. Epub: 19 June 2022. doi:10.2519/jospt.2022.10828

18 March 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
Rubén Fernández-RodríguezRubén Fernández-Rodríguez
Rubén Fernández-Rodríguez
MGMiriam Garrido-Miguel
Miriam Garrido-Miguel
BPBruno Bizzozero Peroni
Bruno Bizzozero Peroni
Valentina Díaz GoñiValentina Díaz Goñi
Valentina Díaz Goñi
EGEva Rodríguez Gutiérrez
Eva Rodríguez Gutiérrez
ATAna Torres-Costoso
Ana Torres-Costoso
Time-restricted eating (TRE) has emerged as a dietary strategy that restricts food consumption to a specific time window and is commonly applied to facilitate weight loss. The benefits of TRE on adipose tissue have been evidenced in human trials and animal models; however, its impact on bone tissue remains unclear. To systematically synthesize and examine the evidence on the impact of TRE on bone health (bone mineral content (BMC), bone mineral density (BMD), and bone turnover factors), PubMed, Scopus, Cochrane CENTRAL, and Web of Science databases were systematically explored from inception to 1 October 2023 searching for randomized controlled trials (RCTs) aimed at determining the effects of TRE on bone health in adults (≥18 years). The Cochrane Handbook and the PRISMA recommendations were followed. A total of seven RCTs involving 313 participants (19 to 68 years) were included, with an average length of 10.5 weeks (range: 4 to 24 weeks). Despite the significant weight loss reported in five out of seven studies when compared to the control, our meta-analysis showed no significant difference in BMD (g/cm2) between groups (MD = −0.009, 95% CI: −0.026 to 0.009, p = 0.328; I2 = 0%). BMC and bone turnover markers between TRE interventions and control conditions were not meta-analyzed because of scarcity of studies (less than five). Despite its short-term benefits on cardiometabolic health, TRE did not show detrimental effects on bone health outcomes compared to those in the control group. Nevertheless, caution should be taken when interpreting our results due to the scarcity of RCTs adequately powered to assess changes in bone outcomes.